ABG Analytics logo
 

Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 02/16/2024
Closing price: 71.58
Support price level: N/A
Resistance price level: $76.94
Relative strength index (14-day RSI) 18.1
Beta 0.34
  • GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • GILD is one of this month's worst performers with a return of -18.0%, underperforming 90 percent of stocks in the S&P-100.

  • Volatility is forecast to fall over the next month.

  • With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$71.58 $87.29 0.0%
200 day 50 day 20 day 10 day
$77.89 $79.97 $76.53 $74.23
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
25.9% 24.1% 27.0% 26.3%
There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than:
  • 7.3% in the next week.

  • 14.9% in the next month.

  • 44.5% in the next year.